Pages that link to "Q52241043"
Jump to navigation
Jump to search
The following pages link to Hematologic Effects of Interleukin-1β, Granulocyte Colony-Stimulating Factor, and Granulocyte-Macrophage Colony-Stimulating Factor in Tumor-bearing Mice Treated With Fluorouracil (Q52241043):
Displaying 11 items.
- Cyclooxygenase-2 is essential for normal recovery from 5-fluorouracil-induced myelotoxicity in mice (Q33330269) (← links)
- The Therapeutic Potential of Interleukin-1 and Tumor Necrosis Factor on Hematopoietic Stem Cells (Q35196479) (← links)
- Clinical applications of granulocyte colony stimulating factor (G-CSF) (Q35337958) (← links)
- Recombinant transforming growth factor beta 1 and beta 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin (Q36363611) (← links)
- Biochemical pharmacology and analysis of fluoropyrimidines alone and in combination with modulators (Q36705141) (← links)
- Interleukin-1: biological effects in human hematopoiesis (Q40828953) (← links)
- Growth factors of the future (Q40833043) (← links)
- Interleukin-1: therapeutic potential for solid tumors (Q40860960) (← links)
- Colony-stimulating factors: a new step in clinical practice. Part II. (Q40877254) (← links)
- Effect of a glucan, sizofiran, on natural-killer activity of 5-fluorouracil-treated murine bone marrow cells (Q67801946) (← links)
- Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF (Q71605724) (← links)